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Abstract
The standard of care for locally advanced carcinoma
of uterine cervix is concurrent chemoradiation therapy
followed by intracavitary brachytherapy, when there is para-
aortic lymphadenopathy, radiation field needs to be
extended to para-aortic region. In the latter case dose
limiting organs are spinal cord, kidneys and small intestine.
We present a challenging case of FIGO IVB squamous cell
carcinoma of cervix and a pelvic kidney. This patient
received chemoradiation to pelvis and para-aortic field,
brachytherapy was not performed as patient already had
undergone attempted hysterectomy. Treatment, outcome
and challenges encountered in this case are presented and
literature is reviewed.
Keywords: Ectopic kidney, Cervical cancer,
Chemoradiation therapy.
Introduction
The standard of treatment of locally advanced
cervical cancer is concurrent chemoradiation and
brachytherapy.1 Cervical cancer and pelvic kidney is an
uncommon condition and to the best of our knowledge there
have been few reported cases of the simultaneous
occurrence of these two conditions. Our case is probably the
first of its kind, having locally advanced cervical cancer,
paraaortic adenopathy and a pelvic kidney.
The radiation tolerance of kidney is 2000 cGy. The
normally positioned kidneys are outside the standard pelvic
and para aortic fields, but the ectopic pelvic kidney is at risk
of radiation nephritis. Also, late complication of renal
irradiation is the development of hypertension refractory to
medical treatment sometimes necessitating nephrectomy of
radiated kidney.2 We report the case of FIGO IVB cervical
squamous cell cancer with left pelvic kidney which was
treated with extended field pelvic and paraaortic
chemoradiation.
Case Report 
A 54 year patient (Para 6) and a known case of left
pelvic kidney, presented with postmenopausal vaginal
bleeding; she was otherwise in good health. 
General physical examination was unremarkable.
Pelvic examination revealed 5x6 cm fungating mass at
vaginal vault invading adjacent fornices and bilateral
parametria. Cystoscopy and proctosigmoidoscopy was
unremarkable. Preoperative pelvic CT scan showed a 5x5
cm cervical mass and left pelvic kidney. She had undergone
an attempted hysterectomy at another hospital and
histopathology was consistent with squamous cell
carcinoma, with positive resection cervical margins. Staging
PET/CT scan revealed 1.8 cm lymph node (SUV 6.5) in the
left para aortic region at L3/4 interspace and
malpositioned/malrotated left pelvic kidney. No distant
metastases were detected on PET/CT scan. The case was
discussed in Gynaecologic-Oncology tumor board, and
chemoradiation was recommended. A urologist was
consulted for possibility of transposing the kidney into
abdomen which was deemed unfeasible. The risks of long
term complication of renal irradiation were explained to the
family. Patient was planned with 3-D conformal CT
planning. Dimcicapto succinic acid (DMSA) renal scan
revealed the relative function of right normally placed
kidney 57% and that of left pelvic kidney 43%.
Technique Of Extended Field Pelvic And Para
Aortic Radiation Therapy:
Treatment was planned on Eclipse (3-D) treatment
planning system. Isocenter was placed at L 4/5 interspace.
In phase I, para-aortic field was planned using AP/PA fields
and the pelvis was planned using four fields. The dose
prescribed was 45 Gy at 1.8 Gy/fraction five days a week
using 18 MV photon energy. In phase II, pelvis was boosted
to a total dose of 50.4 Gy along a separate small field to the
paraaortic nodal area. In phase III cervical mass was
boosted to a total dose of 65 Gy (Figure-1). She received
weekly Cisplatin at 40 mg/m2 for 6 weeks. The 2/3rd of left
kidney received 32 Gy and 8 % of right normally positioned
kidney received <12 Gy. Tolerance remained well
throughout treatment. 
Results
Pelvic examination was done fortnightly to see the
interim response of disease. Eight weeks after completion of
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chemoradiation, PET/CT scan revealed complete resolution
of the paraaortic lymph nodes and > 80% reduction in the
size of primary cervical mass. She received adjuvant three
cycles of Carboplatin and Paclitaxel chemotherapy. At 24
month follow up, she is free of recurrence and her irradiated
kidney continues to show good excretion of contrast on
PET/CT scan. She will continue to have pelvic
examinations regularly at two monthly intervals. 
Discussion
The simultaneous occurrence of locally advanced
cervical cancer and an ectopic pelvic kidney is an
uncommon condition that presents a challenge to
oncologists. The management requires evaluation of the
renal function before therapy. In this case both kidneys were
normally functioning. However, as she received radical
chemoradiotherapy, the left ectopic kidney was sacrificed.
There is paucity of guidelines of treating such cases,
three reported cases of pelvic kidney and advanced cervical
cancer, two patients with renal transplant and a case of
rectal cancer with pelvic kidney could be found in
literature.2,3 But none of the cases needed extended field
pelvic and para aortic field radiation therapy. 
Lataifah reported a case of left pelvic kidney with
FIGO IIB cervical cancer which was successfully treated
with pelvic chemoradiotherapy and brachytherapy.2 Ripley
reported the treatment of locally advanced cervical cancer in
a patient with renal transplant at M D Anderson Cancer
center, who subsequently developed local recurrence after
22 months.3 This case being presented had para aortic
lymph adenopathy and posed a unique challenge for
treatment, as we had to treat the left pelvic kidney while
keeping the dose to a minimal for the right normally
positioned kidney and at the same time delivering
tumoricidal dose to the para-aortic region.
Prognosis of this stage of disease is reported to be
reasonably good, being two year disease free survival 46%
and overall survival 60% in one study4 and three year
disease free survival 63% in another study.5
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Figure: Location of left pelvic kidney (pink) and Isodose lines of radiation doses.
